Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Sep 3;15(9):e0238641. doi: 10.1371/journal.pone.0238641

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

Inkyung Baik 1,*, Sang Ick Park 2
Editor: Petri Böckerman3
PMCID: PMC7470281  PMID: 32881937

Abstract

Data on the association between alcohol consumption and the risk of type 2 diabetes mellitus (T2DM) have accumulated, but little has been reported about this association in terms of lean T2DM. The present study analyzed 10-year longitudinal data to investigate the association between alcohol consumption and T2DM risk among lean individuals. This prospective study included 2,366 male and female Koreans aged 40–69 years who were free of DM and had a body mass index (BMI) <23 kg/m2 during the baseline period between 2001 and 2012. Information on alcohol consumption, BMI, and incident cases of T2DM were identified by interviews and health examinations. To analyze the association between alcohol consumption and T2DM risk, Cox proportional hazard regression analysis was used. Alcohol drinkers consuming at least 16 g/day of alcohol (2 units/day) who maintained a BMI <23 kg/m2 over 10 years had a significantly higher T2DM risk even after controlling for BMI and potential risk factors. Compared with lifetime abstainers, multivariate hazard ratios (HR) [95% confidence interval] of T2DM were 1.74 [1.02, 2.95] for 16–30 g/day, 2.09 [1.16, 3.77] for 31–60 g/day, and 1.94 [1.07, 3.51] for >60g/day among alcohol drinkers. No protective effect of moderate alcohol consumption <16 g/day on T2DM risk was observed. Age, parental history of DM, and physical inactivity were also significant risk factors for lean T2DM. Alcohol consumption of at least 2 units/day increased T2DM risk among lean individuals. Abstaining from alcohol and physical activity may be beneficial for the prevention of lean T2DM.

Introduction

Epidemiological data on the association between alcohol consumption and the risk of type 2 diabetes mellitus (T2DM) have accumulated. However, dose-response results regarding this association are still inconsistent not only among individual studies but also in meta-analyses [13]. In particular, two recent meta-analysis studies evaluating a potential dose-response association between alcohol consumption and T2DM risk produced conflicting results among men; one found a U-shaped association indicating a protective effect of moderate alcohol consumption on T2DM risk [3], whereas the other observed an almost linear association with no reduction in T2DM risk [2]. However, both studies agreed on a U-shaped association with a protective effect of alcohol consumption on T2DM risk among women [2, 3]. Discrepancies in these sex-specific findings may be partly explained by differences in sex-associated fat distributions related to obesity. Because abdominal obesity, which is more common in men, is a strong risk factor for T2DM, the causal effect of alcohol consumption may be relatively diminished or modified by obesity among men.

T2DM patients who have a normal body mass index (BMI), which generally ranges between 18.5 kg/m2 and 25 kg/m2, are called ‘lean T2DM’ [4]. The prevalence of lean T2DM was estimated to be 6% among Caucasian men and 3% among Caucasian women who were participants in the National Health and Nutrition Examination Survey (NHANES) of the United States (US) [5]. Among Asian populations, higher prevalence estimates have been reported [5, 6]. In the Korean NHANES data collected between 2013 and 2015, the prevalence of lean T2DM was 8% among adults aged 30 years or older, and almost half of T2DM patients had a normal BMI [7]. A recent observational study using a large dataset from the German diabetes registries reported a 2.5-fold higher odds ratio of mortality in lean patients compared with obese patients [8]. However, there is little known about risk factors of T2DM morbidity and mortality among lean individuals. Earlier cross-sectional studies showed that, compared with obese diabetic patients, lean patients were more likely to be males, smokers, and alcohol drinkers [6, 8]. In particular, although there are some data from in vitro and animal model studies supporting the toxic effects of alcohol on pancreatic β-cell in terms of the pathogenesis of T2DM [9, 10], epidemiologic data showing a temporal association between alcohol consumption and the incidence of T2DM among lean individuals are limited. A lack of data on this association may be partly due to a relatively small number of cases of lean T2DM in population-based studies. Because more cases are expected in Asian populations than in non-Asian populations, it would be worthy to investigate this association in a prospective cohort study including Asian adults. Data on the associations of alcohol consumption and other risk factors with the incidence of T2DM among lean individuals may provide insights into the mortality reductions in lean diabetic patients.

The present study analyzed 10-year follow-up data from a prospective cohort study that consists of Korean adults, focusing on lean individuals, particularly those who maintained leanness over the follow-up period. We evaluated a dose-response association between alcohol consumption and T2DM risk and attempted to explore potential causative factors for lean T2DM.

Materials and methods

Study population

A population-based prospective study included male and female Koreans aged 40 to 69 years at baseline who were recruited as cohort participants from two cities, Ansan and Ansung. This study was initiated in 2001 to 2002 and is still ongoing as a part of the Korean Genome Epidemiology Study (KoGES). Detailed information on the study design and procedures is available elsewhere [11, 12]. Eligible cohort members who were selected via two-stage cluster sampling based on geographic and demographic characteristics were invited to visit either the Korea University Ansan Hospital or the Ajou University Medical Center for baseline health examination and questionnaire-based interview. Thus, 4,752 men and 5,261 women were initially registered during the period of June 18, 2001 to January 29, 2003. The questionnaire captured data on socio-demographics, medical history and health conditions, family disease history, and lifestyle information, including smoking history and dietary intake, as well as alcohol consumption. Health examinations and interviews have been conducted biennially by trained researchers according to standardized protocols.

The present study analyzed data only for lean individuals with a BMI ranging from 17 kg/m2 to 22.9 kg/m2, which is the range for Asians used in earlier reports [6, 13]. Since the outcome of interest in this study was incident cases of T2DM, participants who were identified to have T2DM at baseline were excluded. Additionally, those who reported a diagnosis of cancer or cardiovascular disease at baseline were excluded. After making these exclusions, a total of 2338 participants (1186 men and 1152 women) were included in the analysis.

Ethics statement

All procedures of the cohort study were performed in accordance with the Declaration of Helsinki. The study protocol was approved by the Human Subjects Review Committee either at the Korea University Ansan Hospital (IRB approval No. ED0624) or at the Ajou University Medical Center (IRB approval No. AJIRB-CRO-06-039) and written informed consent was obtained from all participants. The study datasets, which were anonymized and available for research purposes, were obtained from the Korea Centers for Disease Control and Prevention. The Human Subjects Review Committee of Kookmin University (KMU-201512-HR-094) approved the use of the datasets for this study.

T2DM as an outcome variable

The outcome of interest in this study was incident cases of T2DM, which was defined as the use of insulin or oral glucose-lowering medication or a fasting blood glucose level ≥126 mg/dL, or a 2-hour post-load glucose level ≥200 mg/dL in a 75-g oral glucose tolerance test. Fasting and postprandial plasma specimens were collected in every visit for health examination and sent to a commercial laboratory for assays.

Alcohol consumption as an exposure variable

Information on alcohol consumption was collected from baseline and follow-up questionnaires, which included questions about current and past alcohol consumption status and the amounts of specific alcoholic beverages consumed [12]. Participants were asked whether they had consumed alcoholic beverages at any time during their lifetimes and whether they had stopped consuming alcohol. Furthermore, they were requested to provide information on alcohol consumption during the past year, including the average frequency of drinking occasions, amount of alcohol (beer, wine, hard liquor, and traditional alcoholic drinks such as soju, chungju, and makgeolli) consumed on a typical occasion, and the volume of 1 standard drink for each alcoholic beverage. Using this information, the daily amount of alcohol consumed (g/day) was calculated and used to classify participants into five alcohol drinking groups; 0.1–5 g/day, 6–15 g/day, 16–30 g/day, 31–60 g/day, and >60 g/day. As reported in a previous study [12], the amount of alcohol consumption was strongly correlated with serum concentrations of γ-glutamyltransferase (GGT); Spearman correlation coefficient = 0.49, p-value <0.001. As non-drinking groups, lifetime abstainers and former drinkers who had abstained from alcohol consumption since the previous year were classified separately. In this study, baseline information on alcohol consumption was updated with biennial follow-up data assuming that alcohol consumption status is a changeable lifestyle factor.

Other variables

Information on other potential risk factors including age, sex, income status, occupation, educational level, marital status, smoking status, family history of DM, waist circumference, physical activity level, and calorie intake was collected from the baseline data. Information on body weight and height, which were measured by a trained researchers in every visit for health examination, was collected from the baseline and 10-year follow-up data to calculate BMI. Detailed methodological information on anthropometric measurements and evaluations of physical activity and dietary intake is described elsewhere [12, 14].

Statistical analysis

Descriptive statistics on the baseline characteristics of study participants were calculated according to the categories of alcohol consumption. Comparisons of characteristics across the categories were evaluated using trend tests of chi-square analysis and ANOVA. To analyze the association of a 10-year risk of T2DM with alcohol consumption and other potential risk factors, Cox proportional hazards regression analysis was used. The person-years of each participant were calculated from the date when he or she participated in the baseline examination to the date when he or she reported the first T2DM events in the follow-up examinations or until death or to December 31, 2012, whichever came first. Participants who died, or refused further participation, or were lost to follow-up were censored. The median duration of follow-up used for analysis was 8.6 years. The multivariate risk of T2DM is expressed as a hazard ratio (HR) with its 95% confidence interval (CI). In the multivariate model, age and BMI as continuous variables and sex, household income (wage <106 Won/month or ≥106 Won/month), occupation (office worker or non-office worker), education (<9 years or ≥9 years), marital status (married or other), parental history of DM (yes or no), smoking status (never smoked, former smoker, current smoker; <10 cigarettes/day, 11–20 cigarettes/day, >20 cigarettes/day), physical activity (quintiles of daily metabolic equivalent score), and dietary calorie intake (quintiles) as categorical variables were adjusted for. Further analyses for participants who maintained leanness through to the end of the follow-up period and sex-specific analyses were conducted. To select significant variables in the multivariate model, the stepwise method was used. All testing was based on a two-sided significance level of 0.05. SAS version 9.1.3 (SAS Institute, Cary, NC, USA) was used for all statistical analyses.

Results

It was observed that mean daily alcohol consumption was about 20g in alcohol drinkers. In terms of the types of alcoholic beverage, a major type was soju (mean consumption: 17g of alcohol/day), which is a distilled alcoholic beverage.

Table 1 presents the descriptive statistics of the baseline characteristics for 2338 study participants across the categories of alcohol consumption.

Table 1. Baseline characteristics of 2,338 study subjects across alcohol consumption groups.

Variables Lifetime Former Average alcohol consumption (g/day) P-value
abstainer drinker 0.1–5 6–15 16–30 31–60 >60 for trend
Number of subjects (%) 1138 (48.7) 149 (6.4) 382 (16.3) 255 (10.9) 175 (7.5) 130 (5.6) 109 (4.7)
Age, years 52.5±9.5 56.5±8.9 50.8±8.9 50.9±9.1 50.9±8.3 50.9±9.5 52.5±9.6 <0.01
Men, % 25.5 85.2 46.6 81.2 89.2 93.9 97.3 <0.001
Low household incomea, % 38.6 49.7 32.9 30.6 28.0 29.2 48.6 0.08
Office workers, % 4.9 8.7 8.9 11.4 9.1 10.8 9.2 <0.001
Education >9 years, % 41.0 37.6 48.2 54.9 53.7 49.2 46.8 <0.001
Married, % 88.2 91.3 91.1 93.7 93.1 95.4 92.7 <0.001
Current smokers, % 14.4 49.7 26.7 48.6 55.4 63.1 67.0 <0.001
Family history of diabetes mellitus, % 8.8 5.4 9.2 7.5 8.0 4.6 11.0 0.54
Body mass index, kg/m2 21.2±1.3 21.0±1.4 21.3±1.3 21.2±1.4 21.2±1.4 21.2±1.4 21.1±1.4 0.84
Waist circumference, cm 73.8±6.4 76.6±5.5 74.1±5.8 75.5±5.5 75.9±5.3 77.4±4.8 77.4±5.9 <0.001
Physical activity, MET-hours/d 30.5±15.6 35.3±17.0 32.2±15.7 32.1±15.9 32.2±16.1 34.2±17.3 38.7±17.8 <0.001
Dietary calorie intake, kcal/d 1812±616 1869±696 1856±578 1897±523 1867±477 1960±582 1935±665 <0.05
Biochemical assays
    Glucose, mg/dL 84.9±7.7 87.0±9.0 85.9±8.3 87.4±8.4 87.8±8.9 88.0±9.2 90.4±9.3 <0.001
    Insulin, μU/mL 6.68±4.67 6.42±4.09 6.33±3.15 6.06±5.11 5.62±2.62 5.36±2.70 5.40±2.65 <0.001
    HOMA-IR 1.41±1.05 1.39±0.88 1.35±0.71 1.31±1.08 1.23±0.62 1.17±0.59 1.22±0.63 <0.01
    HOMA-β 123.1±126.3 108.1±91.1 110.9±66.4 100.4±100.7 90.5±53.4 93.1±73.8 77.3±44.2 <0.001
    Total cholesterol, mg/dL 190.1±32.9 189.6±35.7 187.4±34.0 189.6±32.9 189.6±33.4 187.7±37.0 184.3±36.0 0.49
    HDL cholesterol, mg/dL 52.4±11.9 52.6±12.9 53.4±12.4 54.7±12.4 56.9±14.2 54.4±11.9 59.3±15.8 <0.001
    Triglycerides, mg/dL 111.7±62.6 133.1±94.5 110.4±61.1 116.6±63.9 130.4±109.6 141.1±86.9 153.3±152.6 <0.001
    γ-Glutamyl transferase, mU/mL 19.3±21.7 47.5±86.1 28.0±50.2 38.5±53.0 44.6±64.0 84.3±192.8 103.7±174.6 <0.001

MET-hours, Metabolic equivalent score; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β-cell. Data are means±standard deviations or proportions.

a Monthly income <106 Won.

Alcohol drinkers were more likely to be males, office workers, married, and smokers, and have a higher educational level or larger waist circumference, and engage in more activity, with increased calorie intake. They also had higher blood levels of glucose (fasting), total cholesterol, HDL-cholesterol, triglycerides, and GGT. Alcohol drinkers had lower levels of insulin (fasting) and Homeostasis Model Assessment of β-cell (HOMA-β) than lifetime abstainers. Former drinkers also showed lower HOMA-β levels and higher levels of triglycerides and GGT than lifetime abstainers.

Table 2 shows the results of the association between alcohol consumption and T2DM risk.

Table 2. Association between alcohol consumption and 10-year incidence of type 2 diabetes mellitus.

Hazard ratio (95% confidence interval)
Lifetime Former Current drinker: average alcohol consumption (g/day)
abstainer drinker 0.1–5 6–15 16–30 31–60 >60
All participants with BMI <23 kg/m2 at baseline (n = 2338)
Number of subjects (% of cases) 1138 (9.4) 149 (15.4) 382 (10.5) 255 (10.2) 175 (15.4) 130 (13.1) 109 (18.4)
    Age and sex-adjusted reference 1.45 (0.90, 2.35) 1.24 (0.85, 1.79) 1.07 (0.68, 1.70) 1.66 (1.04, 2.63) 1.42 (0.82, 2.46) 1.77 (1.05, 2.96)
    Multivariate adjusteda reference 1.50 (0.92, 2.45) 1.26 (0.87, 1.83) 1.07 (0.68, 1.71) 1.63 (1.02, 2.61) 1.55 (0.89, 2.70) 1.74 (1.03, 2.94)
Participants with BMI <23 kg/m2 over 10 years (n = 2014)
Number of subjects (% of cases) 982 (9.3) 137 (16.1) 329 (9.7) 219 (9.1) 148 (14.2) 108 (14.8) 91 (17.6)
    Age and sex-adjusted reference 1.64 (0.99, 2.74) 1.19 (0.79, 1.80) 1.02 (0.61, 1.71) 1.67 (0.99, 2.82) 1.87 (1.05, 3.33) 1.92 (1.08, 3.42)
    Multivariate adjusteda reference 1.67 (0.99, 2.79) 1.22 (0.80, 1.84) 0.99 (0.58, 1.66) 1.74 (1.02, 2.95) 2.09 (1.16, 3.77) 1.94 (1.07, 3.51)

BMI, body mass index.

a Adjusted for age (continuous), sex, household income (wage <106 Won/month or +106 Won/month), occupation (office worker or non-office worker), educational level (<9 years or +9 years), marital status (married or other), parental history of diabetes mellitus (yes or no), smoking status (never smoked, former smoker, current smoker; <10 cigarettes/day, 11–20 cigarettes/day, +21 cigarettes/day), body mass index (continuous), quintiles of metabolic equivalent score, and quintiles of dietary calorie intake.

Among all study participants, alcohol consumption ≥16 g/day increased the risk of T2DM. In particular, those who maintained leanness over the follow-up period showed stronger associations even after controlling for other potential risk factors. Compared with lifetime abstainers, alcohol drinkers had multivariate HRs (95% CI) of 1.74 (1.02, 2.95) for 16–30 g/day, 2.09 (1.16, 3.77) for 31–60 g/day, and 1.94 (1.07, 3.51) for >60 g/day of average alcohol consumption. There was no reduction in the T2DM risk among alcohol drinkers who consumed 15 g/day or less, nor was there among former drinkers, compared with lifetime abstainers

The results of the sex-specific analyses are presented in Table 3.

Table 3. Sex-specific association between alcohol consumption and 10-year incidence of type 2 diabetes mellitus among participants who maintained leanness over the follow-up period.

Hazard ratio (95% confidence interval)
Lifetime Former Current drinker: average alcohol consumption (g/day)
abstainer drinker ≤15 16–30 >30
Men with BMI <23 kg/m2 over 10 years (n = 1,026)
Number of participants (% of cases) 250 (12.0) 120 (15.0) 333 (9.6) 133 (14.3) 190 (16.8)
    Age-adjusted reference 1.36 (0.76, 2.45) 0.99 (0.60, 1.62) 1.47 (0.83, 2.62) 1.78 (1.08, 2.93)
    Multivariate adjusteda reference 1.31 (0.72, 2.38) 0.92 (0.56, 1.53) 1.52 (0.84, 2.74) 1.83 (1.09, 3.06)
Women with BMI <23 kg/m2 over 10 years (n = 988)
Number of participants (% of cases) 732 (8.3) 17 (23.5) 215 (9.3) 24 (8.3)b
    Age-adjusted reference 3.63 (1.30, 10.10) 1.29 (0.77, 2.15) 1.46 (0.36, 6.02)
    Multivariate adjusteda reference 2.96 (1.02, 8.64) 1.32 (0.77, 2.26) 1.54 (0.36, 6.53)

BMI, body mass index.

a Adjusted for age (continuous), household income (wage <106 Won/month or +106 Won/month), occupation (office worker or non-office worker), educational level (<9 years or +9 years), marital status (married or other), parental history of diabetes mellitus (yes or no), smoking status (never smoked, former smoker, current smoker; <10 cigarettes/day, 11–20 cigarettes/day, +21 cigarettes/day), body mass index (continuous), quintiles of metabolic equivalent score, and quintiles of dietary calorie intake.

b The categories of 16–30 g/day, 31–60 g/day, and > 60 g/day have been combined due to small numbers of cases.

Among participants who maintained leanness over the follow-up period, compared with lifetime abstainers, increased risks of T2DM were observed in male drinkers consuming ≥16 g/day, and a significant risk was observed among those with alcohol consumption >30 g/day. Among women, former drinkers had a significantly increased risk, whereas drinkers consuming ≥16 g/day did not. Relative to lifetime abstainers, the former drinkers had a multivariate HR (95% CI) of 2.96 (1.02, 8.64) in females. No significant risk reduction was observed in associations with light to moderate alcohol consumption among male and female drinkers.

Table 4 demonstrates the results regarding significant factors associated with T2DM risk obtained from the stepwise analysis for 2014 participants who maintained leanness over the follow-up period.

Table 4. Stepwise results on the association between alcohol consumption and 10-year incidence of type 2 diabetes mellitus in 2,014 participants who maintained leanness over the follow-up period.

Variables Hazard ratio (95% confidence interval)
Age 1.04 (1.02, 1.05)
Parental history of diabetes mellitus 2.66 (1.81, 3.91)
Physical activity 1st quintile reference
2nd quintile 0.61 (0.38, 0.99)
3rd quintile 0.63 (0.41, 0.96)
4th quintile 0.70 (0.49, 1.01)
5th quintile 0.54 (0.36, 0.81)
Alcohol consumption Lifetime abstainer reference
Former drinker 1.87 (1.17, 2.99)
Current drinker with ≤15 g/day 1.21 (0.86, 1.71)
Current drinker with 16–30 g/day 1.87 (1.16, 3.01)
Current drinker with >30 g/day 2.20 (1.46, 3.31)

Stepwise analysis included age, household income, occupation, educational level, marital status, parental history of diabetes mellitus, smoking status, body mass index, waist circumference, quintiles of metabolic equivalent score, and quintiles of dietary calorie intake.

At a significance level of 0.05, age, parental history of DM, physical activity, and alcohol consumption were finally included in the model. Participants in the top quintile of physical activity level had a 46% (95% CI: 19%, 64%) reduction in the risk of T2DM. Those with a parental history of DM, as well as those with alcohol consumption ≥16 g/day, were found to have an approximately two-fold higher risk of developing T2DM compared with their respective reference categories. Regardless of the inclusion of waist circumference in the model, the same results were obtained because waist circumference was not significantly associated with T2DM risk in these participants.

Discussion

The present study investigated the association of alcohol consumption and potential risk factors with T2DM risk among lean individuals with a BMI ranging from 17 kg/m2 to 22.9 kg/m2. Alcohol consumption ≥2 units/day (≥16 g/day) significantly increased T2DM risk. Additionally, physical activity reduced the T2DM risk independent of age, parental history of DM, and alcohol consumption.

The Korean Diabetes Association recently reported that approximately 14% of Korean adults aged 30 years or older have T2DM and half of them are obese [15]. Thus, the remaining half of Korean adults with T2DM are underweight or have normal body weights, whereas only 12.5% of individuals with T2DM are lean in the US [16]. In terms of ethnicity, Asians are the major contributors and are disproportionately represented among people classified as having lean T2DM in the US [5, 6]. The proportion of individuals with a BMI <25 kg/m2 was 8.4% among German T2DM patients and between 3% and 6% among Caucasian T2DM patients in the US [5, 8]. In contrast, the pooled data for Asian populations included in 22 prospective cohort studies revealed that 65% and 39% of T2DM patients had a BMI <25 kg/m2 and a BMI <23 kg/m2, respectively [17]. Potential risk factors in the causal pathway leading to lean T2DM are still unclear, although some genetic studies have proposed susceptibility genes [1719], and a few cross-sectional studies have suggested male gender, smoking, and alcohol consumption [6, 8].

The present prospective study attempted to explore risk factors for lean T2DM with a particular focus on alcohol consumption because previous findings regarding its association with T2DM risk have been conflicting [13]. Some of the associations differ between the sexes and among different ethnicities [2], and this may reflect sex- and ethnicity-associated obesity patterns, given that obesity is a well-known and strong risk factor for T2DM. Thus, we investigated whether alcohol consumption is a potential risk factor for T2DM among lean individuals. We observed that current drinkers who consumed ≥2 units/day of alcohol had a significantly higher risk of developing T2DM compared with lifetime abstainers. Former drinkers, notably in females, also had an increased risk of T2DM, suggesting that they should not be included in the reference group as abstainers. If former drinkers were included in the reference group with lifetime abstainers, the current drinkers would have had a falsely reduced risk of T2DM, resulting in a U-shaped association curve [1]. We found that former drinkers had elevated glucose levels and reduced HOMA-β cell levels, indicating impaired glucose tolerance and pancreatic β-cell dysfunction compared with lifetime abstainers. These findings suggest that women might often cease their alcohol consumption at the pre-diabetic stage, probably as part of a conscious effort to modify behavioral factors associated with T2DM and overall health.

In terms of biological mechanisms underlying the association between alcohol consumption and T2DM risk, alcohol produces reactive oxidative species, which impair β-cell mitochondrial function leading to apoptosis [9, 10, 20]. This leads not only to the direct effects of alcohol at the cellular level but also to the consequences of alcohol metabolism, such as acetaldehyde toxicity and excess fatty acid and triglyceride synthesis, which may contribute to the development of T2DM [21].

In this study, we have demonstrated age, parental history of DM, physical activity, and alcohol consumption as significant factors associated with T2DM risk among lean individuals. We estimated a similar effect size for family history of DM as that reported by a previous study, which suggested that family history of DM may reflect genetic susceptibility to DM, adiposity, and other environmental components shared within family members [22]. Genetic susceptibility has been reported to be stronger in lean T2DM than in obese T2DM [18, 23]. Nevertheless, physical activity remained a significant factor in the model independent of age and parental history of DM, and these findings are compatible with previous findings [22]. Thus, regardless of aging and family history of DM, increasing physical activity and abstaining from alcohol may be practical strategies for lean individuals to prevent T2DM. Furthermore, intervention opportunities through health policies and educational programs should be provided to all alcohol drinkers at a high-risk of T2DM.

There are some potential limitations that should be taken into account when interpreting our results. First, information on alcohol consumption was collected via face-to-face, questionnaire-based interviews. This method might make heavy alcohol drinkers underreport alcohol consumption. Second, we observed a lack of association between current alcohol consumption and T2DM risk among women likely because of the small numbers of heavy drinkers. Third, there might be residual confounding in the associations; however, we considered a broad range of potential confounding factors. On the other hand, our study had several strengths, including its prospective design, the use of detailed (in particular, defining lifetime abstainers and former drinkers separately) and updated information on alcohol consumption, and the use of assayed blood glucose levels to define cases. Because the health surveys were administered by trained researchers, the number of non-responders (1.2%) was trivial. The study findings regarding the risk factors for lean T2DM are novel and may be generalizable for Asian populations with low or normal BMIs.

In summary, this prospective study, including middle-aged and older Koreans with low or normal BMIs, observed that any amount of alcohol consumed is not beneficial and alcohol consumption ≥2 units/day significantly increased T2DM risk. Additionally, high physical activity levels decreased T2DM risk, whereas age and parental history of DM increased the risk. On the basis of these findings, abstaining from alcohol and increasing physical activity may be beneficial for the prevention of lean T2DM.

Data Availability

All relevant data are within the manuscript.

Funding Statement

National Research Foundation of Korea Grant funded by the Korean Government (NRF-2019R1A2C2084000) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32. 10.2337/dc09-0227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Knott C, Bell S, Britton A. Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. Diabetes Care. 2015;38(9):1804–12. 10.2337/dc15-0710 [DOI] [PubMed] [Google Scholar]
  • 3.Li XH, Yu FF, Zhou YH, He J. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am J Clin Nutr. 2016;103(3):818–29. 10.3945/ajcn.115.114389 [DOI] [PubMed] [Google Scholar]
  • 4.George AM, Jacob AG, Fogelfeld L. Lean diabetes mellitus: An emerging entity in the era of obesity. World J Diabetes. 2015;6(4):613–20. 10.4239/wjd.v6.i4.613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gujral UP, Mohan V, Pradeepa R, Deepa M, Anjana RM, Narayan KM. Ethnic differences in the prevalence of diabetes in underweight and normal weight individuals: The CARRS and NHANES studies. Diabetes Res Clin Pract. 2018;146:34–40. 10.1016/j.diabres.2018.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Coleman NJ, Miernik J, Philipson L, Fogelfeld L. Lean versus obese diabetes mellitus patients in the United States minority population. J Diabetes Complications. 2014;28(4):500–5. 10.1016/j.jdiacomp.2013.11.010 [DOI] [PubMed] [Google Scholar]
  • 7.Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3). Sejong: Korea Centers for Disease Control and Prevention; 2016. [Google Scholar]
  • 8.Hartmann B, Lanzinger S, Bramlage P, Groß F, Danne T, Wagner S, et al. Lean diabetes in middle-aged adults: A joint analysis of the German DIVE and DPV registries. PLoS One. 2017;12(8):e0183235 10.1371/journal.pone.0183235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dembele K, Nguyen KH, Hernandez TA, Nyomba BL. Effects of ethanol on pancreatic beta-cell death: interaction with glucose and fatty acids. Cell Biol Toxicol 2009;25(2):141–52 10.1007/s10565-008-9067-9 [DOI] [PubMed] [Google Scholar]
  • 10.Ji Yeon Kim Eun Hyun Song, Hyun Jung Lee Yeo Kyoung Oh, Yoon Shin Park Joo-Won Park, et al. Chronic Ethanol Consumption-induced Pancreatic β-Cell Dysfunction and Apoptosis through Glucokinase Nitration and Its Down-regulation. J Biol Chem. 2010;285(48):37251–62. 10.1074/jbc.M110.142315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kim Y, Han BG; KoGES group. Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2017;46(4):1350 10.1093/ije/dyx105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Baik I, Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr 2008;87(5):1455–63. 10.1093/ajcn/87.5.1455 [DOI] [PubMed] [Google Scholar]
  • 13.WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63. 10.1016/S0140-6736(03)15268-3 [DOI] [PubMed] [Google Scholar]
  • 14.Baik I, Abbott RD, Curb JD, Shin C. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc. 2010;110(7):1018–26. 10.1016/j.jada.2010.04.013 [DOI] [PubMed] [Google Scholar]
  • 15.KDA. Diabetes Fact Sheet in Korea 2018. Seoul: Korean Diabetes Association; 2018. [Google Scholar]
  • 16.Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017. [Google Scholar]
  • 17.Timpson NJ, Lindgren CM, Weedon MN, Randall J, Ouwehand WH, Strachan DP, et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes. 2009;58(2):505–10. 10.2337/db08-0906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Perry JR, Voight BF, Yengo L, Amin N, Dupuis J, Ganser M, et al. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet. 2012;8(5):e1002741 10.1371/journal.pgen.1002741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kong X, Xing X, Hong J, Zhang X, Yang W. Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population: A case-control study. Medicine (Baltimore). 2016;95(23):e3841 10.1097/MD.0000000000003841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Albano E. Alcohol, Oxidative Stress and Free Radical Damage. Proc Nutr Soc. 2006;65(3):278–90. 10.1079/pns2006496 [DOI] [PubMed] [Google Scholar]
  • 21.Munukutla S, Pan G, Deshpande M, Thandavarayan RA, Krishnamurthy P, Palaniyandi SS. Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble? Alcohol Clin Exp Res. 2016;40(4):686–97. 10.1111/acer.13008 [DOI] [PubMed] [Google Scholar]
  • 22.Consortium InterAct, Scott RA, Langenberg C, Sharp SJ, Franks PW, Rolandsson O, et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia. 2013;56(1):60–9. 10.1007/s00125-012-2715-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Langenberg C, Sharp SJ, Franks PW, Scott RA, Deloukas P, Forouhi NG, et al. Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med. 2014;11(5):e1001647 10.1371/journal.pmed.1001647 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Petri Böckerman

29 May 2020

PONE-D-20-03085

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

PLOS ONE

Dear Dr. Baik,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The revised version should address all comments in the reports.

Please submit your revised manuscript by Jul 13 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Petri Böckerman

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for including your ethics statement: 

"Human Subjects Review Committee of Kookmin University (KMU-201512-HR-094)".

a. Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study.

b. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3. In your Abstract and discussion sections, please ensure to revise statements of causation (such as "To prevent lean T2DM, abstaining from alcohol and physical activity should be encouraged"), as they are not supported by the observational nature of the present study.

4. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses.

For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Referee report on "Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study" (PONE-D-20-03085)

In this paper, the authors examined associations between alcohol consumption and the risk of type 2 diabetes mellitus (T2DM) among lean Korean adults. Based on the results, alcohol drinkers who consumed alcohol at least 16g/day were more likely to develop T2DM over a 10 -year period than life-time abstainers. Physical activity decreased the risk of T2DM. Obesity is one of the leading risk factors of T2DM but risk factors among lean individuals have received less attention. The article is very clear and pleasant to read. However, I wish there was a bit more elaboration on the context. I am also somewhat concerned about the number of observations which seems to be low in some regressions. Below are my comments on this paper.

1. In the introduction, it should be explicitly stated, why it is important to investigate the incidence of T2DM among lean individuals.

2. Why alcohol consumption may affect the incidence of T2DM? On pages 19-20 the authors provide one potential explanation but I suppose there are also other explanations? I would like to see discussion of why alcohol consumption may affect the incidence of T2DM already in the introduction.

3. Not only the volume but also patterns of drinking may have implications on the association between alcohol consumption and health. For example, the type of alcohol (e.g. wine vs. spirits) and the way alcohol is consumed (e.g. with meals vs. binge drinking) may have implications on the association between alcohol consumption and T2DM. The authors have access to detailed information on alcohol consumption. They could utilize their data to explore whether different patterns of drinking have implications on their results or at least discuss the potential role of different drinking patterns.

4. It looks like the number of individuals (number of cases) does not sum up to n = 2338 in table 2 and the same problem applies also to Table 3. Also, if I read the tables correctly, the number of observations in some groups seems to be very low (< 20 in Table 2 and < 10 in Table 3) which makes it very challenging to detect reasonable-size effects with reasonable power.

5. The authors note that including both lifetime abstainers and former drinkers to the reference group would lead to biased conclusions. This finding has been reported also elsewhere (see e.g. Baliunas et al. 2009) and the authors could refer to these studies as well.

6. Data description: Page 4, line 69: “A population-based prospective study included male and female Koreans aged 40 to 69 years”. Please clarify, was this the age at the baseline (if not, when)? Also, please clarify whether information on BMI (and T2DM) were based on self-reported information or medical examinations.

References

Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., & Rehm, J. (2009). Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes care, 32(11), 2123-2132.

Reviewer #2: Comments

1. The exact contribution to the (international) literature should be stated in the revised introduction.

2. What is the motivation for the focus on Korea?

3. The paper uses information on health surveys. Was non-response to the surveys random or not? This information would be useful in order to better understand the estimation results. If those with least physical activity are less likely to respond to the health surveys, the estimates that are obtained may be biased, at least to some degree. This issue should be noted in the paper.

4. Do the data contain (survey) weights or not? Why they have not been used in the estimations?

5. Do the models contain the relevant controls? Physical activity is linked to education (https://doi.org/10.1111/sms.13653). This issue should be noted in the revised version.

6. The paper does not consider the potential heterogeneity in the estimated effects. The relationships can differ significantly e.g. by gender.

7. The concluding section of the paper should discuss more about the practical policy lessons that can be drawn from the estimation results.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 3;15(9):e0238641. doi: 10.1371/journal.pone.0238641.r002

Author response to Decision Letter 0


2 Jul 2020

Re: PONE-D-20-03085

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

Here are our responses to the comments for the above-referenced manuscript.

Response to the Reviewer #1’s comments:

1. In the introduction, it should be explicitly stated, why it is important to investigate the incidence of T2DM among lean individuals.

Response: Thank you for your valuable comments. We revised the Introduction part according to the comment (lines 60-68, revised).

2. Why alcohol consumption may affect the incidence of T2DM? On pages 19-20 the authors provide one potential explanation but I suppose there are also other explanations? I would like to see discussion of why alcohol consumption may affect the incidence of T2DM already in the introduction.

Response: We agree on this opinion. We revised the Introduction part according to the comment (lines 60-68, revised).

3. Not only the volume but also patterns of drinking may have implications on the association between alcohol consumption and health. For example, the type of alcohol (e.g. wine vs. spirits) and the way alcohol is consumed (e.g. with meals vs. binge drinking) may have implications on the association between alcohol consumption and T2DM. The authors have access to detailed information on alcohol consumption. They could utilize their data to explore whether different patterns of drinking have implications on their results or at least discuss the potential role of different drinking patterns.

Response: In terms of alcoholic beverages, almost all alcohol drinkers consumed ‘soju’, which is a major type of alcoholic beverage in Korea and similar to ‘sake’. So, we were unable to conduct separate analyses according to the types of alcoholic beverage. The information on the consumption of meals or specific foods in the occasion of alcohol drinking was unavailable. Among alcohol drinkers who consumed 30g/day or greater, about 20% were binge drinkers. We found no significant association between binge drinking and T2DM partly due to a small number of binge drinkers. We now added information on the types of alcoholic beverage (lines 166-168, revised).

4. It looks like the number of individuals (number of cases) does not sum up to n = 2338 in table 2 and the same problem applies also to Table 3. Also, if I read the tables correctly, the number of observations in some groups seems to be very low (< 20 in Table 2 and < 10 in Table 3) which makes it very challenging to detect reasonable-size effects with reasonable power.

Response: We have now corrected the number of participants (Tables 2 and 3, revised).

5. The authors note that including both lifetime abstainers and former drinkers to the reference group would lead to biased conclusions. This finding has been reported also elsewhere (see e.g. Baliunas et al. 2009) and the authors could refer to these studies as well.

Response: Thank you for this comment. The original list of references included the study of Baliunas et al. (2009). We added the reference number of this article in the Discussion part (line 260, revised).

6. Data description: Page 4, line 69: “A population-based prospective study included male and female Koreans aged 40 to 69 years”. Please clarify, was this the age at the baseline (if not, when)? Also, please clarify whether information on BMI (and T2DM) were based on self-reported information or medical examinations.

Response: We have now clarified the description regarding age, BMI, and T2DM according to the comment (lines 110-111 and 137-138, revised).

Response to the Reviewer #2’s comments:

1. The exact contribution to the (international) literature should be stated in the revised introduction.

Response: Thank you for your valuable comments. We re-checked out all references quoted in the Introduction part. The reference 7 was added (line 58) because we estimated the prevalence of lean T2DM in a Korean population using the Korean NHANES data. There was no previous literature regarding such an estimate.

2. What is the motivation for the focus on Korea?

Response: We added the text regarding the motivation (lines 64-68, revised).

3. The paper uses information on health surveys. Was non-response to the surveys random or not? This information would be useful in order to better understand the estimation results. If those with least physical activity are less likely to respond to the health surveys, the estimates that are obtained may be biased, at least to some degree. This issue should be noted in the paper.

Response: Because the health surveys were administered by trained researchers, the number of non-responders to the surveys including specific questions on physical activity was trivial. Thus, we think that the effects of non-responders on the study findings were insignificant. We have now noted this aspect in the manuscript (lines 294-295, revised).

4. Do the data contain (survey) weights or not? Why they have not been used in the estimations?

Response: The present study used data from a whole cohort and applied the inclusion and exclusion criteria. If the study used data from a sample which was selected from an original cohort, survey weights might have been considered in the analysis.

5. Do the models contain the relevant controls? Physical activity is linked to education (https://doi.org/10.1111/sms.13653). This issue should be noted in the revised version.

Response: The models included educational level with other potential confounding factors. This issue has been noted in the line 290.

6. The paper does not consider the potential heterogeneity in the estimated effects. The relationships can differ significantly e.g. by gender.

Response: We agree on this comment. Because we also thought that the associations can differ by gender, we presented data stratified by gender in Table 3.

7. The concluding section of the paper should discuss more about the practical policy lessons that can be drawn from the estimation results.

Response: We have now added a text according to the comment (lines 282-283, revised).

Response to the editor’s comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response: We checked it out.

2. Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study.

Response: We have now revised the ethics statement (lines 97-105, revised).

3. In your Abstract and discussion sections, please ensure to revise statements of causation (such as "To prevent lean T2DM, abstaining from alcohol and physical activity should be encouraged"), as they are not supported by the observational nature of the present study.

Response: We have now revised it (lines 35-36, revised).

4. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated.

Response: Because of the copyright that The Korea Centers for Disease Control & Prevention owns, we are unable to provide a questionnaire copy. In terms of the validity of alcohol consumption, additional information has been now added (lines 124-127, revised).

Attachment

Submitted filename: Responses to Reviewers.docx

Decision Letter 1

Petri Böckerman

20 Jul 2020

PONE-D-20-03085R1

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

PLOS ONE

Dear Dr. Baik,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The revised version should address the remaining comments.

Please submit your revised manuscript by Sep 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Petri Böckerman

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I think the paper has improved. However, there are still two issues the authors should consider.

1. I asked the authors to explain in the introduction, why it is important to investigate the incidence of T2DM among lean individuals. The only explanation they give is that there is not much previous evidence on this topic. However, I think just the fact that there is not much evidence does not justify the topic. So, why is it important to investigate the incidence of T2DM among lean individuals?

2. Reviewer 2 brought up an excellent point about non-response. In the revised version, the authors state that “Because the health surveys were administrated by trained researchers, the number of non-responders was trivial”. As long as a survey is voluntary, there is a significant risk that non-random non-response occurs. The authors should provide exact information concerning non-response.

Reviewer #2: I am happy with the revised version of the paper. I like the research question, the structure of the paper, the quality of writing, and the way the authors describe their empirical proceeding and results. Most importantly, the authors have addressed all the issues stated in my referee report for the first version appropriately.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 3;15(9):e0238641. doi: 10.1371/journal.pone.0238641.r004

Author response to Decision Letter 1


5 Aug 2020

Re: PONE-D-20-03085

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

Here are our responses to the comments for the above-referenced manuscript.

Response to the Reviewer #1’s comments:

Reviewer #1:

1. I asked the authors to explain in the introduction, why it is important to investigate the incidence of T2DM among lean individuals. The only explanation they give is that there is not much previous evidence on this topic. However, I think just the fact that there is not much evidence does not justify the topic. So, why is it important to investigate the incidence of T2DM among lean individuals?

Response: Thank you for further comments. We have now added contents related to the importance of research for lean T2DM (lines 58-60 and 70-72, revised).

2. Reviewer 2 brought up an excellent point about non-response. In the revised version, the authors state that “Because the health surveys were administrated by trained researchers, the number of non-responders was trivial”. As long as a survey is voluntary, there is a significant risk that non-random non-response occurs. The authors should provide exact information concerning non-response.

Response: We have now added the exact proportion of non-responders (1.2%) (line 299, revised).

Reviewer #2: I am happy with the revised version of the paper. I like the research question, the structure of the paper, the quality of writing, and the way the authors describe their empirical proceeding and results. Most importantly, the authors have addressed all the issues stated in my referee report for the first version appropriately.

Response: Thank you very much for your valuable comments.

Attachment

Submitted filename: Responses to Reviewers_2v.docx

Decision Letter 2

Petri Böckerman

21 Aug 2020

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

PONE-D-20-03085R2

Dear Dr. Baik,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Petri Böckerman

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: I am happy with the revised version of the paper. I like the research question, the structure of the paper, the quality of writing, and the way the authors describe their empirical proceeding and results. Most importantly, the authors have addressed all the issues stated in my referee report for the first version appropriately.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Petri Böckerman

26 Aug 2020

PONE-D-20-03085R2

Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study

Dear Dr. Baik:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Petri Böckerman

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Responses to Reviewers.docx

    Attachment

    Submitted filename: Responses to Reviewers_2v.docx

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES